Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Harvard Business School
Baxter
Medtronic
AstraZeneca

Last Updated: June 26, 2022

CLINICAL TRIALS PROFILE FOR RHINOCORT ALLERGY


✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Rhinocort Allergy

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
New Formulation NCT00641979 ↗ New Nasal Applicator / New Formulation - User Study Completed AstraZeneca Phase 2 2002-04-01 The purpose of this study is to compare the efficacy of once daily dosing with Rhinocort Aqua (new formulation) against Rhinocort Aqua (current formulation) and placebo in reliving the symptoms of seasonal allergic rhinitis (SAR).
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Rhinocort Allergy

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00560586 ↗ Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome Completed University of Louisville Phase 4 2004-04-01 -Intranasal budesonide therapy may lead to improved symptoms and sleep study findings in children with mild obstructive sleep apnea with and without allergic rhinitis that would not be treated with T&A. The aim of the study is to conduct a randomized double blind cross-over trial comparing the effect of once a day intranasal budesonide therapy vs. placebo in children with mild sleep apnea that would not be candidates for T&A.
NCT00641212 ↗ Children, Perennial Allergic Rhinitis (PAR), l-t Growth Completed AstraZeneca Phase 4 2000-01-01 The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.
NCT00641680 ↗ Rhinocort Aqua Versus Placebo and Fluticasone Propionate Completed AstraZeneca Phase 3 2003-04-01 The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Rhinocort Allergy

Condition Name

Condition Name for Rhinocort Allergy
Intervention Trials
Seasonal Allergic Rhinitis 4
Allergic Rhinitis 2
Rhinitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Rhinocort Allergy
Intervention Trials
Rhinitis 9
Rhinitis, Allergic 7
Rhinitis, Allergic, Seasonal 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Rhinocort Allergy

Trials by Country

Trials by Country for Rhinocort Allergy
Location Trials
Canada 3
China 3
United States 2
Thailand 1
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Rhinocort Allergy
Location Trials
North Carolina 1
Kentucky 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Rhinocort Allergy

Clinical Trial Phase

Clinical Trial Phase for Rhinocort Allergy
Clinical Trial Phase Trials
Phase 4 4
Phase 3 3
Phase 2 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Rhinocort Allergy
Clinical Trial Phase Trials
Completed 10
Recruiting 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Rhinocort Allergy

Sponsor Name

Sponsor Name for Rhinocort Allergy
Sponsor Trials
AstraZeneca 4
Ligand Pharmaceuticals 2
National Cancer Institute (NCI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Rhinocort Allergy
Sponsor Trials
Industry 10
Other 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.